Back to search

United States· US:72205-438_1cfa51fd-8406-404c-b2a8-0fc1068675fb

DAPAGLIFLOZIN AND SAXAGLIPTIN

A saxagliptin and dapagliflozin product containing dapagliflozin; saxagliptin hydrochloride dihydrate, registered in United States by Novadoz Pharmaceuticals LLC. The same ATC class is registered in 11 of our 19 countries.

ATC A10BD21US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDAPAGLIFLOZIN AND SAXAGLIPTINATCA10BD21REGISTER NO.US:72205-438_1cfa51fd…PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Saxagliptin and dapagliflozin is registered in 11 of 19 countries.

Countries holding a registration under ATC A10BD21 (saxagliptin and dapagliflozin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Saxagliptin and dapagliflozin · ATC A10BD21

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE
Manufacturer
Novadoz Pharmaceuticals LLC
Country
United States (US)
ATC code
A10BD21
ATC class
Saxagliptin and dapagliflozin
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    7220543801
    30 TABLET, FILM COATED in 1 BOTTLE (72205-438-01)
  • ndc11
    7220543802
    90 TABLET, FILM COATED in 1 BOTTLE (72205-438-02)
  • ndc11
    72205-438-01
  • ndc11
    72205-438-02

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Saxagliptin and dapagliflozin in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All saxagliptin and dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Qtern
  • Liechtenstein · Qtern
  • Norway · Qtern

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8b6560fc-0a0b-4332-9233-9ae062edf8aa
GET /v1/drugs/8b6560fc-0a0b-4332-9233-9ae062edf8aa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10; 5",
  "substance": "DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE",
  "productndc": "72205-438",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "ANDA211533",
  "marketing_category": "ANDA"
}

See everything about saxagliptin and dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.